Northern Trust Company of Connecticut’s Alnylam Pharmaceuticals ALNY Stock Holding History

Northern Trust Company of Connecticut's ALNY Position: Q4 2013 in Review

Northern Trust Company of Connecticut increased its Alnylam Pharmaceuticals (ALNY) stake by 39% in Q4 2013, buying an estimated $349K and bringing the position to 20,776 shares worth $1.34M. The position accounts for 0.01% of the portfolio, ranked #1250.

Northern Trust Company of Connecticut first reported a position in ALNY in Q2 2013 and has held it in 3 quarters since. 169 funds tracked by Wall St. Rank hold ALNY as of Q4 2013.

• Northern Trust Company of Connecticut held 20,776 shares of Alnylam Pharmaceuticals worth $1.34M as of Q4 2013.
• Northern Trust Company of Connecticut bought 5,854 Alnylam Pharmaceuticals shares in Q4 2013, an estimated $349K.
• Alnylam Pharmaceuticals made up 0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1250 holding.
• Northern Trust Company of Connecticut first reported a position in Alnylam Pharmaceuticals in Q2 2013 and has held it in 3 quarters since.
• 169 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.